Acquist is a team of dedicated and high-energy individuals who appreciate a challenging entrepreneurial environment and who contribute daily to our company objectives. We are committed to aggressively leveraging our expertise in inflammation and drug discovery, development, and commercialization.
Acquist is a biopharmaceutical company focused on the identification, development and commercialization of drugs that alter the inflammatory process. Our strategy is to maximize value through excellence in performance and innovation while maintaining the highest standards of integrity and leadership. Acquist is committed to developing innovative products to better the lives of people with chronic inflammatory disorders. The Company’s lead programs are in NASH and chronic gout.